KMT2C and breast cancer: Two recent published studies demonstrated that TP53, ESR1, KMT2C, AKT1, PTEN, and NF1 were more frequently altered in metastatic HR+/HER2− breast cancer compared with the early ones, in accordance with a previous study, indicating their driving role in breast cancer metastasis and relapse (3, 47).